Medical technology company Endotronix is coming to Naperville.
The company, which makes tech used by heart failure patients, said it would move from its current headquarters in Lisle, to a larger space in Naperville, the Chicago Business Journal reported. It will occupy an 80,000-square-foot facility at the HUB 1415 building at 1415 Diehl Road, doubling its footprint.
Endotronix has 100 employees and expects to hire up to 50 more as it prepares for the commercial launch of its Cordella heart failure system and pulmonary artery sensor, pending FDA approval.
The new offices are being renovated to include a cleanroom, as well as space for manufacturing and administration,” Endotronix said in a statement cited by the publication.It will have workspaces designed for a flexible workforce and the first phase of construction is expected to be completed in early 2023.
CEO Harry Rowland said Naperville was an appealing location because it’s affordable and close to Chicago.
Rowland founded Endotronix with Dr. Anthony Nunez in 2013 and created an implantable sensor that detects early signs of worsening heart failure. The company has raised $125 million in nine years.
Naperville officials support the addition of the company to the western Chicago suburb. “It’s a pleasure,” Mayor Steve Chirico said.
Elsewhere in Naperville, a partnership between Opal Holdings and investor Katherine Cartagena paid $73.3 million to buy the former OfficeMax headquarters in April. After the deal for the 354,000-square-foot building at 263 Shuman Avenue splitting the building from the land: Opal bought the leasehold on the property, extending its office buying spree in the Chicago area.
Read more
Commercial
Chicago
Northpond Partners turns profit on sale of Naperville shopping center for $52M
— Victoria Pruitt